Please Wait
Applying Filters...
menu
    • menu
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Duvelisib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 153,970Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Secura Bio Joins Gilmartin Group's 2026 Corporate Access Event
    Secura Bio Joins Gilmartin Group's 2026 Corporate Access Event

    23 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/23/3209780/0/en/Secura-Bio-Announces-Participation-in-Gilmartin-Group-s-2026-Corporate-Access-Event-in-San-Francisco.html

    GLOBENEWSWIRE
    23 Dec 2025
    Share Share
    Secura Bio Updates Progress In Phase 3 TERZO Study
    Secura Bio Updates Progress In Phase 3 TERZO Study

    22 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/22/3209090/0/en/Secura-Bio-Provides-Corporate-Update-and-Highlights-Progress-in-its-Phase-3-TERZO-Study.html

    GLOBENEWSWIRE
    22 Dec 2025
    Share Share
    Secura Bio Announces NCCN Update for Duvelisib in CTCL Lymphoma
    Secura Bio Announces NCCN Update for Duvelisib in CTCL Lymphoma

    17 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/17/3206857/0/en/Secura-Bio-Announces-NCCN-Duvelisib-COPIKTRA-Update-to-Clinical-Practice-Guidelines-in-Oncology-for-Cutaneous-T-Cell-Lymphoma-CTCL-Including-Mycosis-Fungoides-and-S%C3%A9zary-Syndrome.html

    GLOBENEWSWIRE
    17 Dec 2025
    Share Share
    Secura Bio Reveals Phase 2 PRIMO Trial Data
    Secura Bio Reveals Phase 2 PRIMO Trial Data

    07 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/07/3201129/0/en/Secura-Bio-Presents-Extended-Follow-Up-Analyses-from-Phase-2-PRIMO-Trial-in-Patients-with-Relapsed-Refractory-peripheral-T-cell-lymphoma-at-the-2025-American-Society-of-Hematology-.html

    GLOBENEWSWIRE
    07 Dec 2025
    Share Share
    Secura Doses First Patient in Ph3 TERZO Study of Copiktra
    Secura Doses First Patient in Ph3 TERZO Study of Copiktra

    09 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/09/3095721/0/en/Secura-Bio-Announces-First-Patient-Dosed-in-Phase-3-TERZO-Study-of-COPIKTRA-duvelisib-in-Relapsed-Refractory-Nodal-T-follicular-Helper-Cell-Lymphoma.html

    GLOBENEWSWIRE
    09 Jun 2025
    Share Share
    Secura Bio Presents Combination Data of COPIKTRA® at ASH 2024
    Secura Bio Presents Combination Data of COPIKTRA® at ASH 2024

    09 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/09/2993617/0/en/New-Combination-Data-of-Secura-Bio-s-COPIKTRA-duvelisib-Presented-at-the-2024-American-Society-of-Hematology-Meeting.html

    GLOBENEWSWIRE
    09 Dec 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.